Fernando Forato Anhê

Fernando Forato Anhê

Auto-generated profile, based on publicly available information

Fernando Forato Anhê

Quebec Heart and Lung Institute Research Center, Université Laval - 2725, Ch. Sainte-Foy, Quebec QC G1V 4G5, Canada

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 August 2022 in Gut
Verified
Journal Article
Open access
PDF file
FAFernando F Anhê
Fernando F Anhê
SZSoumaya Zlitni
Soumaya Zlitni
SZSong-Yang Zhang
Song-Yang Zhang
BCBéatrice So-Yun Choi
Béatrice So-Yun Choi
CCCassandra Y Chen
Cassandra Y Chen
JSJonathan Schertzer
Jonathan Schertzer
Objective: Bariatric surgery is an effective treatment for type 2 diabetes (T2D) that changes gut microbial composition. We determined whether the gut microbiota in humans after restrictive or malabsorptive bariatric surgery was sufficient to lower blood glucose. Design: Women with obesity and T2D had biliopancreatic diversion with duodenal switch (BPD-DS) or laparoscopic sleeve gastrectomy (LSG). Faecal samples from the same patient before and after each surgery were used to colonise rodents, and determinants of blood glucose control were assessed. Results: Glucose tolerance was improved in germ-free mice orally colonised for 7 weeks with human microbiota after either BPD-DS or LSG, whereas food intake, fat mass, insulin resistance, secretion and clearance were unchanged. Mice colonised with microbiota post-BPD-DS had lower villus height/width and crypt depth in the distal jejunum and lower intestinal glucose absorption. Inhibition of sodium-glucose cotransporter (Sglt)1 abrogated microbiota-transmissible improvements in blood glucose control in mice. In specific pathogen-free (SPF) rats, intrajejunal colonisation for 4 weeks with microbiota post-BPD-DS was sufficient to improve blood glucose control, which was negated after intrajejunal Sglt-1 inhibition. Higher Parabacteroides and lower Blautia coincided with improvements in blood glucose control after colonisation with human bacteria post-BPD-DS and LSG. Conclusion: Exposure of rodents to human gut microbiota after restrictive or malabsorptive bariatric surgery improves glycaemic control. The gut microbiota after bariatric surgery is a standalone factor that alters upper gut intestinal morphology and lowers Sglt1-mediated intestinal glucose absorption, which improves blood glucose control independently from changes in obesity, insulin or insulin resistance.

2 September 2022 in Gut
Verified
Journal Article
Closed access
PDF file
LDLaurence Daoust
Laurence Daoust
BCBéatrice S-Y Choi
Béatrice S-Y Choi
AAAnne-Laure Agrinier
Anne-Laure Agrinier
TVThibault V Varin
Thibault V Varin
AOAdia Ouellette
Adia Ouellette
AMAndré Marette
André Marette
Objective Faecal microbiota transplantation (FMT) in germ-free (GF) mice is a common approach to study the causal role of the gut microbiota in metabolic diseases. Lack of consideration of housing conditions post-FMT may contribute to study heterogeneity. We compared the impact of two housing strategies on the metabolic outcomes of GF mice colonised by gut microbiota from mice treated with a known gut modulator (cranberry proanthocyanidins (PAC)) or vehicle. Design High-fat high-sucrose diet-fed GF mice underwent FMT-PAC colonisation in sterile individual positive flow ventilated cages under rigorous housing conditions and then maintained for 8 weeks either in the gnotobiotic-axenic sector or in the specific pathogen free (SPF) sector of the same animal facility. Results Unexpectedly, 8 weeks after colonisation, we observed opposing liver phenotypes dependent on the housing environment of mice. Mice housed in the GF sector receiving the PAC gut microbiota showed a significant decrease in liver weight and hepatic triglyceride accumulation compared with control group. Conversely, exacerbated liver steatosis was observed in the FMT-PAC mice housed in the SPF sector. These phenotypic differences were associated with housing-specific profiles of colonising bacterial in the gut and of faecal metabolites. Conclusion These results suggest that the housing environment in which gnotobiotic mice are maintained post-FMT strongly influences gut microbiota composition and function and can lead to distinctive phenotypes in recipient mice. Better standardisation of FMT experiments is needed to ensure reproducible and translatable results.

1 January 2021 in Journal of Lipid and Atherosclerosis
Verified
Journal Article
Open access
PDF file
FAFernando F. Anhê
Fernando F. Anhê
Benjamin JensenBenjamin Jensen
Benjamin Jensen
LPLais Rossi Perazza
Lais Rossi Perazza
ATAndré Tchernof
André Tchernof
JSJonathan D. Schertzer
Jonathan D. Schertzer
AMAndré Marette
André Marette
Anhê FF, et al. J Lipid Atheroscler. 2021 May;10(2):123-129. https://doi.org/10.12997/jla.2021.10.2.123

5 March 2022 in Physiological Reports
Verified
Journal Article
Open access
FAFernando F. Anhê
Fernando F. Anhê
SZSoumaya Zlitni
Soumaya Zlitni
NBNicole G. Barra
Nicole G. Barra
KFKevin P. Foley
Kevin P. Foley
MNMats I. Nilsson
Mats I. Nilsson
JSJonathan D. Schertzer
Jonathan D. Schertzer
High aerobic endurance capacity can be acquired by training and/or inherited. Aerobic exercise training (AET) and aging are linked to altered gut microbiome composition, but it is unknown if the environmental stress of exercise and host genetics that predispose for higher exercise capacity have similar effects on the gut microbiome during aging. We hypothesized that exercise training and host genetics would have conserved effects on the gut microbiome across different rodents. We studied young sedentary (Y‐SED, 2‐month‐old) mice, old sedentary (O‐SED, 26‐month‐old) mice, old mice with life‐long AET (O‐AET, 26‐month‐old), and aged rats selectively bred for high (HCR [High Capacity Runner], 21‐month‐old) and low (LCR [Low Capacity Runner], 21‐month‐old) aerobic capacity. Our results showed that O‐SED mice had lower running capacity than Y‐SED mice. The fecal microbiota of O‐SED mice had a higher relative abundance of Lachnospiraceae, Ruminococcaceae, Turicibacteriaceae, and Allobaculum, but lower Bacteroidales, Alistipes, Akkermansia, and Anaeroplasma. O‐AET mice had a higher running capacity than O‐SED mice. O‐AET mice had lower fecal levels of Lachnospiraceae, Turicibacteriaceae, and Allobaculum and higher Anaeroplasma than O‐SED mice. Similar to O‐AET mice, but despite no exercise training regime, aged HCR rats had lower Lachnospiraceae and Ruminococcaceae and expansion of certain Bacteroidales in the fecal microbiome compared to LCR rats. Our data show that environmental and genetic modifiers of high aerobic endurance capacity produce convergent gut microbiome signatures across different rodent species during aging. Therefore, we conclude that host genetics and life‐long exercise influence the composition of the gut microbiome and can mitigate gut dysbiosis and functional decline during aging.

22 January 2025 in Molecular Metabolism
Verified
Journal Article
Open access
ESEya Sellami
Eya Sellami
Paulo Henrique Evangelista-SilvaPaulo Henrique Evangelista-Silva
Paulo Henrique Evangelista-Silva
CTCaio Jordão Teixeira
Caio Jordão Teixeira
KDKhoudia Diop
Khoudia Diop
PMPatricia Mitchell
Patricia Mitchell
FAFernando Forato Anhê
Fernando Forato Anhê
Increased fructose consumption contributes to type 2 diabetes (T2D) and metabolic dysfunction-associated steatotic liver disease (MASLD), but the mechanisms are ill-defined. Gut nutrient sensing involves enterohormones like Glucagon-like peptide (Glp)2, which regulates the absorptive capacity of luminal nutrients. While glucose is the primary dietary energy source absorbed in the gut, it is unknown whether excess fructose alters gut glucose sensing to impair blood glucose regulation and liver homeostasis. Mice were fed diets where carbohydrates were either entirely glucose (70 %Kcal) or glucose partially replaced with fructose (8.5 %Kcal). Glp2 receptor (Glp2r) was inhibited with Glp2 (3-33) injections. Glucose tolerance, insulin sensitivity, and gut glucose absorption were concomitantly assessed, and enteric sugar transporters and absorptive surface were quantified by RT-qPCR and histological analysis, respectively. High fructose feeding led to impairment of blood glucose disposal, ectopic fat accumulation in the liver, and hepatic (but not muscle or adipose tissue) insulin resistance independent of changes in fat mass. This was accompanied by increased gut glucose absorption, which preceded glucose intolerance and liver steatosis. Fructose upregulated glucose transporters and enlarged the gut surface, but these effects were prevented by Glp2r inhibition. Blocking Glp2r prevented fructose-induced impairments in glucose disposal and hepatic lipid handling. Excess fructose impairs blood glucose and liver homeostasis by rewiring gut glucose sensing and exacerbating gut glucose absorption. Our findings are positioned to inform novel early diagnostic tools and treatments tailored to counter high fructose-induced metabolic derangements predisposing to T2D and MASLD.

13 January 2022 in STAR Protocols
Verified
Journal Article
Open access
FAFernando F. Anhê
Fernando F. Anhê
ABArshpreet Bhatwa
Arshpreet Bhatwa
JSJonathan D. Schertzer
Jonathan D. Schertzer
Postbiotics cooperate to influence immune and metabolic outcomes in the host. Here we describe a protocol for in vivo assessment of blood glucose control following acute administration of lipopolysaccharide (LPS) and peptidoglycan (PGN) in mice. This protocol can be adapted for testing a broad range of microbial molecules and ligands for host immune receptors. Experience with mouse handling is required.